Beta Bionics (BBNX) Consolidated Net Income (2024 - 2026)

Beta Bionics' Consolidated Net Income history runs 3 years deep, the most recent figure standing at -$21.9 million for Q1 2026.

• In Q1 2026, Consolidated Net Income fell 35.1% year-over-year to -$21.9 million; the TTM figure through Mar 2026 stood at -$66.4 million (down 34.94% YoY), while the FY2025 annual figure was -$60.7 million, down 46.94% from the prior year.
• Consolidated Net Income came in at -$21.9 million for Q1 2026 at Beta Bionics, down from -$13.5 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of -$8.3 million in Q1 2024 to a low of -$21.9 million in Q1 2026.
• A 3-year average of -$13.8 million and a median of -$13.5 million in 2025 frame the typical range for Consolidated Net Income.
• On a YoY basis, Consolidated Net Income climbed as much as 11.42% in 2025 and fell as far as 94.92% in 2025.
• Beta Bionics' Consolidated Net Income stood at -$12.1 million in 2024, then fell by 11.42% to -$13.5 million in 2025, then sank by 62.59% to -$21.9 million in 2026.
• According to Business Quant data, Consolidated Net Income over the past three periods registered -$21.9 million, -$13.5 million, and -$14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison